Obligacje
Poniżej znajduje się lista obligacji korporacyjnych Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs. Inwestorzy często wybierają obligacje spółek ze względu na ich zwiększoną stabilność w czasach zmienności rynkowej. Przeanalizuj ceny, rentowności i inne statystyki, aby znaleźć wiarygodną inwestycję.
Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
|---|---|---|---|---|---|---|---|---|---|
| 5,71% | 0 | 55,02% | 1,625% | 2043-09-14 | 250 M GBP | 1 000,00 GBP | 100 000,00 GBP | Eli Lilly & Co. | |
| 5,65% | 44 K | 88,40% | 4,650% | 2044-06-15 | 38,34 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,53% | 0 | 78,99% | 4,150% | 2059-03-15 | 591,29 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,49% | 11,14 M | 101,70% | 5,600% | 2065-02-12 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,46% | 15,87 M | 102,97% | 5,650% | 2065-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,46% | 4,39 M | 94,21% | 5,100% | 2064-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,46% | 1,22 M | 95,84% | 5,200% | 2064-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,43% | 962 K | 92,26% | 4,950% | 2063-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,43% | 0 | 57,23% | 2,250% | 2050-05-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,38% | 0 | 81,11% | 3,950% | 2049-03-15 | 958,15 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,37% | 5,26 M | 95,23% | 5,050% | 2054-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,37% | 143 K | 92,84% | 4,875% | 2053-02-27 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,37% | 14,42 M | 102,55% | 5,550% | 2055-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,36% | 2,22 M | 94,67% | 5,000% | 2054-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,35% | 0 | 55,17% | 2,500% | 2060-09-15 | 850 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,34% | 1,4 M | 82,30% | 3,950% | 2047-05-15 | 346,95 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,33% | 940 K | 102,38% | 5,500% | 2055-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,29% | 30 K | 80,91% | 3,700% | 2045-03-01 | 386,8 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,23% | 0 | 87,14% | 3,875% | 2039-03-15 | 240,25 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 5,01% | 4 K | 113,94% | 6,770% | 2036-01-01 | 158,56 M USD | 1 000,00 USD | 1 000,00 USD | Eli Lilly & Co. | |
| 4,80% | 540 K | 100,03% | 5,000% | 2026-02-27 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,69% | 15 K | 111,44% | 5,950% | 2037-11-15 | 266,83 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,61% | 13,3 M | 102,28% | 4,900% | 2035-10-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,55% | 4,51 M | 104,09% | 5,100% | 2035-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,51% | 1,04 M | 109,14% | 5,550% | 2037-03-15 | 444,73 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,46% | 6,62 M | 100,96% | 4,600% | 2034-08-14 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,44% | 2,71 M | 101,78% | 4,700% | 2034-02-09 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,40% | 0 | 45,92% | 1,375% | 2061-09-14 | 700 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,26% | 1,59 M | 101,68% | 4,550% | 2032-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,18% | 667 K | 103,91% | 4,900% | 2032-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,09% | 2,66 M | 100,74% | 4,250% | 2031-03-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,08% | 0 | 53,38% | 1,125% | 2051-09-14 | 500 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 4,07% | 379 K | 103,86% | 4,700% | 2033-02-27 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 4,06% | 0 | 64,27% | 1,700% | 2049-11-01 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 3,97% | 1 M | 102,97% | 4,750% | 2030-02-12 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,94% | 0 | 98,27% | 3,375% | 2029-03-15 | 930,56 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,87% | 310 K | 101,14% | 4,200% | 2029-08-14 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,84% | 472 K | 101,96% | 4,500% | 2029-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,80% | 142 K | 100,82% | 4,500% | 2027-02-09 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,74% | 180 K | 102,23% | 5,500% | 2027-03-15 | 364,32 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,73% | 357 K | 100,70% | 4,150% | 2027-08-14 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,70% | 25 K | 99,18% | 3,100% | 2027-05-15 | 401,45 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,68% | 285 K | 101,82% | 4,550% | 2028-02-12 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,64% | 4 M | 100,94% | 4,000% | 2028-10-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. | |
| 3,08% | 0 | 82,32% | 0,500% | 2033-09-14 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,91% | 0 | 87,69% | 0,625% | 2031-11-01 | 600 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,78% | 0 | 97,23% | 2,125% | 2030-06-03 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 2,23% | 0 | 99,69% | 1,625% | 2026-06-02 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Eli Lilly & Co. | |
| 0,51% | 0 | 99,85% | 0,450% | 2028-05-24 | 400 M CHF | 5 000,00 CHF | 5 000,00 CHF | Eli Lilly & Co. | |
| — | 8,85 M | 100,58% | 4,764% | 2028-10-15 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Eli Lilly & Co. |